Healthcare provider profile · identity verified

Syed Abbas, M.D.

Family Practice · HOUSTON, TX · NPI 1821267477

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	658	93
Amlodipine Besylate	Amlodipine Besylate	625	94
Furosemide	Furosemide	474	58
Levothyroxine Sodium	Levothyroxine Sodium	442	55
Famotidine	Famotidine	431	47
Gabapentin	Gabapentin	425	47
Eliquis	Apixaban	369	30
Mirtazapine	Mirtazapine	357	50
Sertraline Hcl	Sertraline Hcl	314	40
Tamsulosin Hcl	Tamsulosin Hcl	300	26
Losartan Potassium	Losartan Potassium	299	41
Lisinopril	Lisinopril	269	38
Metoprolol Tartrate	Metoprolol Tartrate	268	30
Metoprolol Succinate	Metoprolol Succinate	244	30
Quetiapine Fumarate	Quetiapine Fumarate	237	32
Pantoprazole Sodium	Pantoprazole Sodium	236	29
Hydralazine Hcl	Hydralazine Hcl	186	18
Memantine Hcl	Memantine Hcl	164	17
Metformin Hcl	Metformin Hcl	154	34
Omeprazole	Omeprazole	146	19
Pravastatin Sodium	Pravastatin Sodium	146	14
Carvedilol	Carvedilol	138	19
Escitalopram Oxalate	Escitalopram Oxalate	138	21
Fluoxetine Hcl	Fluoxetine Hcl	132	suppressed
Potassium Chloride	Potassium Chloride	128	18
Hydrochlorothiazide	Hydrochlorothiazide	122	21
Donepezil Hcl	Donepezil Hcl	121	19
Methenamine Hippurate	Methenamine Hippurate	110	suppressed
Clopidogrel	Clopidogrel Bisulfate	107	suppressed
Risperidone	Risperidone	106	suppressed
Valsartan	Valsartan	105	14
Rosuvastatin Calcium	Rosuvastatin Calcium	103	29
Amiodarone Hcl	Amiodarone Hcl	96	suppressed
Trazodone Hcl	Trazodone Hcl	96	22
Duloxetine Hcl	Duloxetine Hcl	95	15
Levetiracetam	Levetiracetam	89	suppressed
Nifedipine Er	Nifedipine	82	suppressed
Baclofen	Baclofen	81	suppressed
Chlorthalidone	Chlorthalidone	79	11
Myrbetriq	Mirabegron	78	suppressed
Warfarin Sodium	Warfarin Sodium	76	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	75	suppressed
Finasteride	Finasteride	74	suppressed
Citalopram Hbr	Citalopram Hydrobromide	73	suppressed
Montelukast Sodium	Montelukast Sodium	70	11
Simvastatin	Simvastatin	69	14
Prednisone	Prednisone	67	suppressed
Xarelto	Rivaroxaban	67	suppressed
Verapamil Er	Verapamil Hcl	64	suppressed
Bumetanide	Bumetanide	63	suppressed
Atenolol	Atenolol	59	12
Buspirone Hcl	Buspirone Hcl	59	13
Propranolol Hcl	Propranolol Hcl	59	suppressed
Midodrine Hcl	Midodrine Hcl	58	suppressed
Fluticasone Propionate	Fluticasone Propionate	57	34
Divalproex Sodium	Divalproex Sodium	56	suppressed
Folic Acid	Folic Acid	56	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	suppressed
Meloxicam	Meloxicam	53	suppressed
Oxycodone Hcl	Oxycodone Hcl	52	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	50	suppressed
Fenofibrate	Fenofibrate	50	suppressed
Primidone	Primidone	50	suppressed
Tradjenta	Linagliptin	50	suppressed
Bupropion Hcl Sr	Bupropion Hcl	49	suppressed
Ranolazine Er	Ranolazine	49	suppressed
Tramadol Hcl	Tramadol Hcl	49	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	suppressed
Isoniazid	Isoniazid	46	suppressed
Lamotrigine	Lamotrigine	46	suppressed
Latanoprost	Latanoprost	46	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	45	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	45	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	suppressed
Metformin Hcl Er	Metformin Hcl	44	suppressed
Nystatin	Nystatin	43	21
Albuterol Sulfate Hfa	Albuterol Sulfate	41	20
Lorazepam	Lorazepam	41	17
Spironolactone	Spironolactone	41	suppressed
Ibuprofen	Ibuprofen	34	14
Mycophenolate Mofetil	Mycophenolate Mofetil	33	suppressed
Glimepiride	Glimepiride	30	suppressed
Lidocaine	Lidocaine	30	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Azithromycin	Azithromycin	27	26
Pregabalin	Pregabalin	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Jardiance	Empagliflozin	26	11
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Cephalexin	Cephalexin	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	18
Farxiga	Dapagliflozin Propanediol	20	suppressed
Digoxin	Digoxin	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	11
Irbesartan	Irbesartan	18	suppressed
Lacosamide	Lacosamide	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Clonazepam	Clonazepam	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Glipizide	Glipizide	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Enalapril Maleate	Enalapril Maleate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Methimazole	Methimazole	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Rivastigmine	Rivastigmine	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Calcium Acetate	Calcium Acetate	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Meropenem	Meropenem	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Pentasa	Mesalamine	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error